Puma Biotechnology, Inc.
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $27.7M |
| Cost of Revenue | $5.6M |
| Gross Profit | $22.1M |
| Gross Margin | 79.9% |
| Operating Expenses | |
| Research & Development | $207.8M |
| SG&A Expense | $106.7M |
| Operating Income | $-292.4M |
| Operating Margin | -1,056.1% |
| Interest Expense | $720.0K |
| Pretax Income | — |
| Income Tax Expense | $0 |
| Net Income | $-292.0M |
| Net Margin | -1,054.6% |
| EPS (Basic) | $-7.85 |
| EPS (Diluted) | $-7.85 |
| Shares Outstanding (Basic) | 37.6M |
| Shares Outstanding (Diluted) | 37.6M |
| Dividends Per Share | — |